Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $22.0800 (0.68%) ($22.0800 - $22.0800) on Fri. Jan. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.88% (three month average) | RSI | 27 | Latest Price | $22.0800(0.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(64%) IBUY(62%) IWC(62%) IWM(61%) | Factors Impacting EDIT price | EDIT will decline at least -1.94% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-10%) IGOV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.94% (StdDev 3.88%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.21(-67.35%) | Resistance Level | $26.55 | 5 Day Moving Average | $23.79(-7.19%) | 10 Day Moving Average | $24.63(-10.35%) | 20 Day Moving Average | $26.55(-16.84%) | To recent high | -45.8% | To recent low | 0.7% | Market Cap | $1.371b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |